Literature DB >> 2761697

Clinical spectrum of Niemann-Pick disease type C.

J K Fink1, M R Filling-Katz, J Sokol, D G Cogan, A Pikus, B Sonies, B Soong, P G Pentchev, M E Comly, R O Brady.   

Abstract

Analysis of the neurologic symptomatology in 22 patients with Niemann-Pick disease type C revealed 3 phenotypes: (1) an early-onset, rapidly progressive form associated with severe hepatic dysfunction and psychomotor delay during infancy and later with supranuclear vertical gaze paresis, ataxia, marked spasticity, and dementia; (2) a delayed-onset, slowly progressive form heralded by the appearance, usually in early childhood, of mild intellectual impairment, supranuclear vertical gaze paresis, and ataxia, and later associated with dementia and, variably, seizures and extrapyramidal deficits; (3) a late-onset slowly progressive form distinguished from the 2nd pattern by later age of onset (adolescence or adulthood) and a much slower rate of progression. The existence of the 1st and 2nd phenotypes within the same sibship suggests that they are variant expressions of the same clinicopathologic disorder. Niemann-Pick disease type C should be considered not only in infants and children who present with organomegaly and a progressive neurodegenerative course, but also in adolescents and adults who have insidiously progressive neurologic dysfunction and only slight organomegaly. Associated with the disease is a marked deficiency in the ability of cultured fibroblasts to esterify exogenously supplied cholesterol. Assay of this deficiency is particularly useful for confirming the diagnosis in patients with atypical presentation.

Entities:  

Mesh:

Year:  1989        PMID: 2761697     DOI: 10.1212/wnl.39.8.1040

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  29 in total

1.  Gender and age differences in expression of GABAA receptor subunits in rat somatosensory thalamus and cortex in an absence epilepsy model.

Authors:  Huifang Li; John R Huguenard; Robert S Fisher
Journal:  Neurobiol Dis       Date:  2007-01-05       Impact factor: 5.996

2.  Bone-marrow-derived mesenchymal stem cells promote proliferation and neuronal differentiation of Niemann-Pick type C mouse neural stem cells by upregulation and secretion of CCL2.

Authors:  Hyun Lee; Ji Eun Kang; Jong Kil Lee; Jae-Sung Bae; Hee Kyung Jin
Journal:  Hum Gene Ther       Date:  2013-06-21       Impact factor: 5.695

3.  The usefulness of bone marrow aspiration in the diagnosis of Niemann-Pick disease type C in infantile liver disease.

Authors:  A F Rodrigues; R G Gray; M A Preece; R Brown; F G Hill; U Baumann; P J McKiernan
Journal:  Arch Dis Child       Date:  2006-05-31       Impact factor: 3.791

4.  Isolated splenomegaly as the presenting feature of Niemann-Pick disease type C.

Authors:  J Imrie; J E Wraith
Journal:  Arch Dis Child       Date:  2001-05       Impact factor: 3.791

5.  Liver biopsies in patients with lysosomal storage disease: experience with effective sedation.

Authors:  R P Grewal; K T Yu; N W Barton; R I Parker; A M Bisceglie
Journal:  Indian J Pediatr       Date:  1997 Nov-Dec       Impact factor: 1.967

Review 6.  Cholesterol in Niemann-Pick Type C disease.

Authors:  Xiaoning Bi; Guanghong Liao
Journal:  Subcell Biochem       Date:  2010

7.  Tau deletion exacerbates the phenotype of Niemann-Pick type C mice and implicates autophagy in pathogenesis.

Authors:  Chris D Pacheco; Matthew J Elrick; Andrew P Lieberman
Journal:  Hum Mol Genet       Date:  2008-12-12       Impact factor: 6.150

8.  Neurofibrillary tangles in Niemann-Pick disease type C.

Authors:  K Suzuki; C C Parker; P G Pentchev; D Katz; B Ghetti; A N D'Agostino; E D Carstea
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

Review 9.  Gene Therapy for the Treatment of Neurological Disorders: Metabolic Disorders.

Authors:  Dominic J Gessler; Guangping Gao
Journal:  Methods Mol Biol       Date:  2016

10.  Progressive subcortical gliosis and progressive supranuclear palsy can have similar clinical and PET abnormalities.

Authors:  N L Foster; S Gilman; S Berent; A A Sima; C D'Amato; R A Koeppe; S P Hicks
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-08       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.